Article

PAP 2023: Vijesh Unnikrihnan Discusses Preparing for Strategy and Planning Issues

Vijesh Unnikrihnan describes how his experience across the board aids in being ready for strategy and planning issues.

In an interview with Pharma Commerce Editor, Nicholas Saraceno, Vijesh Unnikrihnan, digital health strategy lead, ZS, explains his experience in preparing for strategy and planning issues.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!
Related Videos
Related Content
Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes
August 5th 2025

Asembia 2025: What Pharma Leaders Must Know About Tariffs, Supply Chains, and Policy Changes

Don Tracy, Associate Editor
The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system.
Asembia 2025: The Cost of Care for Patients
August 5th 2025

Asembia 2025: The Cost of Care for Patients

Nicholas Saraceno, Editor
Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that specialty pharmacies can play in helping to tackle these issues.
Asembia 2025: Rethinking the Drug Distribution Process
August 5th 2025

Asembia 2025: Rethinking the Drug Distribution Process

Nicholas Saraceno, Editor
A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.
Asembia 2025: Understanding the Inflation Reduction Act
August 5th 2025

Asembia 2025: Understanding the Inflation Reduction Act

Nicholas Saraceno, Editor
A seminar shares key observations and learnings from the first round of direct price negotiations.
Asembia 2025: Rare Disease Therapies Drive Shift in Drug Development Focus
August 5th 2025

Asembia 2025: Rare Disease Therapies Drive Shift in Drug Development Focus

Don Tracy, Associate Editor
Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.
Asembia 2025: A General Landscape of the Pharmaceutical Industry
August 5th 2025

Asembia 2025: A General Landscape of the Pharmaceutical Industry

Nicholas Saraceno, Editor
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
© 2025 MJH Life Sciences

All rights reserved.